- Home
- RAYA vs COEP Comparison
RAYA vs COEP Comparison
Compare RAYA & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAYA | COEP |
|---|---|---|
| Founded | 2019 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 100.4M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | RAYA | COEP |
|---|---|---|
| Price | $4.04 | $14.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 29.4K | ★ 117.0K |
| Earning Date | 04-17-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,101,325.00 | $500,996.00 |
| Revenue This Year | $20.95 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.78 | N/A |
| 52 Week Low | $3.13 | $2.31 |
| 52 Week High | $736.99 | $21.41 |
Technical Indicators
Market Signals| Indicator | RAYA | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 46.80 | 43.24 |
| Support Level | $4.20 | $13.61 |
| Resistance Level | $4.50 | $15.40 |
| Average True Range (ATR) | 0.47 | 1.07 |
| MACD | -0.04 | -0.09 |
| Stochastic Oscillator | 17.77 | 29.77 |
Price Performance
Historical ComparisonAbout RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.